Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 65 of 95, showing 5 Applications out of 474 total, starting on record 321, ending on 325

# Protocol No Study Title Investigator(s) & Site(s)

321.

ECCT/18/04/01   CKAF156 STUDY
    A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. KEMRI CDC (Siaya county)
2. Walter Reed Project (Kisumu county)
 
View

322.

ECCT/19/12/02   VPM1002 Phase III PoI
    A multicenter, Phase III double blind, randomized active controlled study to evaluate efficacy and safety of VPM1002 in comparison with BCG in prevention of Mycobacterium tuberculosis infection in newborn infants.     
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI-CRDR Nairobi (Nairobi City county)
2. KEMRI-CRDR Siaya (Siaya county)
 
View

323.

ECCT/24/01/01   SAVIS
    A Phase 1 Clinical Study to Evaluate the Safety and Immunogenicity of a Novel GMMA Vaccine Against Invasive Non-Typhoidal Salmonella in healthy Kenyan adults.      
Principal Investigator(s)
1. ANTHONY SCOTT
Site(s) in Kenya
KEMRI Centre for Geographical Medicine Research Coast
 
View

324.

ECCT/21/02/04   GASTROSAM
     GASTROSAM   Gastroenteritis: Rehydration of children with severe acute malnutrition   
Principal Investigator(s)
1. Professor Kathryn Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View

325.

ECCT/20/09/02   BEe-HIVe
     B-ENHANCEMENT OF HBV VACCINATIONIN PERSONS LIVING WITH HIV (BEe-HIVe) EVALUATION OF HEPLISAV-B,A5379   
Principal Investigator(s)
1. JOSPHAT KOSGEI
Site(s) in Kenya
KEMRI/KERICHO CLINIC RESEARCH CENTRE
 
View